Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ATF2
|
ENSG00000115966.12 | activating transcription factor 2 |
ATF1
|
ENSG00000123268.4 | activating transcription factor 1 |
ATF3
|
ENSG00000162772.12 | activating transcription factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ATF3 | hg19_v2_chr1_+_212782012_212782257 | -0.67 | 2.4e-05 | Click! |
ATF1 | hg19_v2_chr12_+_51158263_51158395 | 0.26 | 1.5e-01 | Click! |
ATF2 | hg19_v2_chr2_-_176032843_176032941 | -0.18 | 3.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_+_139456226 | 7.91 |
ENST00000367658.2
|
HECA
|
headcase homolog (Drosophila) |
chr19_+_1941117 | 4.95 |
ENST00000255641.8
|
CSNK1G2
|
casein kinase 1, gamma 2 |
chr5_-_175965008 | 4.89 |
ENST00000537487.1
|
RNF44
|
ring finger protein 44 |
chr7_-_105926058 | 4.36 |
ENST00000417537.1
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr19_-_46088068 | 4.31 |
ENST00000263275.4
ENST00000323060.3 |
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) |
chr11_-_77185094 | 4.31 |
ENST00000278568.4
ENST00000356341.3 |
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1 |
chr7_-_142120321 | 4.21 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
chr7_-_140624499 | 3.96 |
ENST00000288602.6
|
BRAF
|
v-raf murine sarcoma viral oncogene homolog B |
chr7_+_142031986 | 3.94 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
chr6_-_34664612 | 3.84 |
ENST00000374023.3
ENST00000374026.3 |
C6orf106
|
chromosome 6 open reading frame 106 |
chr7_-_142099977 | 3.66 |
ENST00000390359.3
|
TRBV7-8
|
T cell receptor beta variable 7-8 |
chr12_-_92539614 | 3.57 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
chr15_+_76629064 | 3.56 |
ENST00000290759.4
|
ISL2
|
ISL LIM homeobox 2 |
chr14_+_68086515 | 3.23 |
ENST00000261783.3
|
ARG2
|
arginase 2 |
chr14_+_22180536 | 3.20 |
ENST00000390424.2
|
TRAV2
|
T cell receptor alpha variable 2 |
chr22_+_44568825 | 3.08 |
ENST00000422871.1
|
PARVG
|
parvin, gamma |
chrX_+_49832231 | 3.03 |
ENST00000376108.3
|
CLCN5
|
chloride channel, voltage-sensitive 5 |
chr7_-_142149390 | 3.02 |
ENST00000390372.3
|
TRBV5-5
|
T cell receptor beta variable 5-5 |
chr18_+_61554932 | 2.98 |
ENST00000299502.4
ENST00000457692.1 ENST00000413956.1 |
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
chr7_+_142020496 | 2.94 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
chr7_-_142247606 | 2.93 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
chr8_+_42195972 | 2.88 |
ENST00000532157.1
ENST00000265421.4 ENST00000520008.1 |
POLB
|
polymerase (DNA directed), beta |
chr7_-_142232071 | 2.85 |
ENST00000390364.3
|
TRBV10-1
|
T cell receptor beta variable 10-1(gene/pseudogene) |
chr19_-_47616992 | 2.78 |
ENST00000253048.5
|
ZC3H4
|
zinc finger CCCH-type containing 4 |
chr1_-_26701003 | 2.77 |
ENST00000455900.1
|
ZNF683
|
zinc finger protein 683 |
chr19_-_48547294 | 2.74 |
ENST00000293255.2
|
CABP5
|
calcium binding protein 5 |
chr3_+_38206975 | 2.72 |
ENST00000446845.1
ENST00000311806.3 |
OXSR1
|
oxidative stress responsive 1 |
chr12_+_56511943 | 2.71 |
ENST00000257940.2
ENST00000552345.1 ENST00000551880.1 ENST00000546903.1 ENST00000551790.1 |
ZC3H10
ESYT1
|
zinc finger CCCH-type containing 10 extended synaptotagmin-like protein 1 |
chr5_-_172198190 | 2.70 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr19_+_1954632 | 2.66 |
ENST00000589350.1
|
CSNK1G2
|
casein kinase 1, gamma 2 |
chr7_-_142111859 | 2.62 |
ENST00000390378.1
|
TRBV5-7
|
T cell receptor beta variable 5-7 (non-functional) |
chr6_+_15249128 | 2.59 |
ENST00000397311.3
|
JARID2
|
jumonji, AT rich interactive domain 2 |
chr3_+_16306691 | 2.58 |
ENST00000285083.5
ENST00000605932.1 ENST00000435829.2 |
OXNAD1
|
oxidoreductase NAD-binding domain containing 1 |
chr9_+_116298778 | 2.56 |
ENST00000462143.1
|
RGS3
|
regulator of G-protein signaling 3 |
chr12_-_107168696 | 2.55 |
ENST00000551505.1
|
RP11-144F15.1
|
Uncharacterized protein |
chr11_-_3818688 | 2.54 |
ENST00000355260.3
ENST00000397004.4 ENST00000397007.4 ENST00000532475.1 |
NUP98
|
nucleoporin 98kDa |
chr7_-_142131914 | 2.50 |
ENST00000390375.2
|
TRBV5-6
|
T cell receptor beta variable 5-6 |
chr6_-_41254403 | 2.47 |
ENST00000589614.1
ENST00000334475.6 ENST00000591620.1 ENST00000244709.4 |
TREM1
|
triggering receptor expressed on myeloid cells 1 |
chr2_+_30454390 | 2.45 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
chr17_-_4890649 | 2.44 |
ENST00000361571.5
|
CAMTA2
|
calmodulin binding transcription activator 2 |
chr8_+_42196000 | 2.42 |
ENST00000518925.1
ENST00000538005.1 |
POLB
|
polymerase (DNA directed), beta |
chr5_+_172332220 | 2.41 |
ENST00000518247.1
ENST00000326654.2 |
ERGIC1
|
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
chr12_-_64616019 | 2.39 |
ENST00000311915.8
ENST00000398055.3 ENST00000544871.1 |
C12orf66
|
chromosome 12 open reading frame 66 |
chr14_-_50053081 | 2.39 |
ENST00000396020.3
ENST00000245458.6 |
RPS29
|
ribosomal protein S29 |
chr14_-_55369525 | 2.36 |
ENST00000543643.2
ENST00000536224.2 ENST00000395514.1 ENST00000491895.2 |
GCH1
|
GTP cyclohydrolase 1 |
chr5_-_99870932 | 2.36 |
ENST00000504833.1
|
CTD-2001C12.1
|
CTD-2001C12.1 |
chr11_+_128563652 | 2.30 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr6_-_91006627 | 2.30 |
ENST00000537989.1
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
chr19_-_51014460 | 2.28 |
ENST00000595669.1
|
JOSD2
|
Josephin domain containing 2 |
chrX_+_10126488 | 2.27 |
ENST00000380829.1
ENST00000421085.2 ENST00000454850.1 |
CLCN4
|
chloride channel, voltage-sensitive 4 |
chr19_+_50979753 | 2.26 |
ENST00000597426.1
ENST00000334976.6 ENST00000376918.3 ENST00000598585.1 |
EMC10
|
ER membrane protein complex subunit 10 |
chr18_+_77155856 | 2.26 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr7_-_142240014 | 2.21 |
ENST00000390363.2
|
TRBV9
|
T cell receptor beta variable 9 |
chr16_+_50775948 | 2.18 |
ENST00000569681.1
ENST00000569418.1 ENST00000540145.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr6_-_91006461 | 2.16 |
ENST00000257749.4
ENST00000343122.3 ENST00000406998.2 ENST00000453877.1 |
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
chr7_-_142176790 | 2.14 |
ENST00000390369.2
|
TRBV7-4
|
T cell receptor beta variable 7-4 (gene/pseudogene) |
chr19_+_1065922 | 2.13 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr11_-_3818932 | 2.12 |
ENST00000324932.7
ENST00000359171.4 |
NUP98
|
nucleoporin 98kDa |
chr12_-_12715266 | 2.11 |
ENST00000228862.2
|
DUSP16
|
dual specificity phosphatase 16 |
chr8_+_126442563 | 2.10 |
ENST00000311922.3
|
TRIB1
|
tribbles pseudokinase 1 |
chr6_+_64281906 | 2.10 |
ENST00000370651.3
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
chr8_-_17104099 | 2.10 |
ENST00000524358.1
|
CNOT7
|
CCR4-NOT transcription complex, subunit 7 |
chr2_-_74781061 | 2.08 |
ENST00000264094.3
ENST00000393937.2 ENST00000409986.1 |
LOXL3
|
lysyl oxidase-like 3 |
chr7_-_129592700 | 2.08 |
ENST00000472396.1
ENST00000355621.3 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
chr12_-_123380610 | 2.07 |
ENST00000535765.1
|
VPS37B
|
vacuolar protein sorting 37 homolog B (S. cerevisiae) |
chr2_-_202645612 | 2.06 |
ENST00000409632.2
ENST00000410052.1 ENST00000467448.1 |
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile) |
chr3_+_16306837 | 2.05 |
ENST00000606098.1
|
OXNAD1
|
oxidoreductase NAD-binding domain containing 1 |
chrX_+_12993202 | 2.04 |
ENST00000451311.2
ENST00000380636.1 |
TMSB4X
|
thymosin beta 4, X-linked |
chr8_+_38243721 | 2.02 |
ENST00000527334.1
|
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
chr5_+_133707252 | 2.01 |
ENST00000506787.1
ENST00000507277.1 |
UBE2B
|
ubiquitin-conjugating enzyme E2B |
chr12_+_9066472 | 2.01 |
ENST00000538657.1
|
PHC1
|
polyhomeotic homolog 1 (Drosophila) |
chr12_+_22778291 | 2.01 |
ENST00000545979.1
|
ETNK1
|
ethanolamine kinase 1 |
chr2_+_70142189 | 1.99 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
chr7_-_142169013 | 1.98 |
ENST00000454561.2
|
TRBV5-4
|
T cell receptor beta variable 5-4 |
chr11_+_117049854 | 1.98 |
ENST00000278951.7
|
SIDT2
|
SID1 transmembrane family, member 2 |
chr19_-_51014345 | 1.96 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
chr2_-_145188137 | 1.95 |
ENST00000440875.1
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
chr8_-_66754172 | 1.95 |
ENST00000401827.3
|
PDE7A
|
phosphodiesterase 7A |
chr6_-_38607673 | 1.93 |
ENST00000481247.1
|
BTBD9
|
BTB (POZ) domain containing 9 |
chr17_-_4890919 | 1.91 |
ENST00000572543.1
ENST00000381311.5 ENST00000348066.3 ENST00000358183.4 |
CAMTA2
|
calmodulin binding transcription activator 2 |
chr22_+_25003568 | 1.91 |
ENST00000447416.1
|
GGT1
|
gamma-glutamyltransferase 1 |
chr4_+_170581213 | 1.90 |
ENST00000507875.1
|
CLCN3
|
chloride channel, voltage-sensitive 3 |
chr20_+_33292507 | 1.89 |
ENST00000414082.1
|
TP53INP2
|
tumor protein p53 inducible nuclear protein 2 |
chr1_+_203274639 | 1.88 |
ENST00000290551.4
|
BTG2
|
BTG family, member 2 |
chr19_+_24009879 | 1.88 |
ENST00000354585.4
|
RPSAP58
|
ribosomal protein SA pseudogene 58 |
chr13_+_111767650 | 1.85 |
ENST00000449979.1
ENST00000370623.3 |
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
chr2_+_219745020 | 1.84 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
chr14_+_21498666 | 1.84 |
ENST00000481535.1
|
TPPP2
|
tubulin polymerization-promoting protein family member 2 |
chr3_-_101395936 | 1.83 |
ENST00000461821.1
|
ZBTB11
|
zinc finger and BTB domain containing 11 |
chr6_+_35227247 | 1.83 |
ENST00000469195.1
|
ZNF76
|
zinc finger protein 76 |
chr22_+_25003606 | 1.83 |
ENST00000432867.1
|
GGT1
|
gamma-glutamyltransferase 1 |
chr18_+_77155942 | 1.82 |
ENST00000397790.2
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr7_+_89975979 | 1.82 |
ENST00000257659.8
ENST00000222511.6 ENST00000417207.1 |
GTPBP10
|
GTP-binding protein 10 (putative) |
chr11_-_6633799 | 1.81 |
ENST00000299424.4
|
TAF10
|
TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa |
chr5_-_16509101 | 1.81 |
ENST00000399793.2
|
FAM134B
|
family with sequence similarity 134, member B |
chr17_+_55333876 | 1.80 |
ENST00000284073.2
|
MSI2
|
musashi RNA-binding protein 2 |
chr20_+_44420570 | 1.78 |
ENST00000372622.3
|
DNTTIP1
|
deoxynucleotidyltransferase, terminal, interacting protein 1 |
chr17_-_8151353 | 1.78 |
ENST00000315684.8
|
CTC1
|
CTS telomere maintenance complex component 1 |
chr16_+_68056844 | 1.77 |
ENST00000565263.1
|
DUS2
|
dihydrouridine synthase 2 |
chr22_-_39096981 | 1.77 |
ENST00000427389.1
|
JOSD1
|
Josephin domain containing 1 |
chr16_+_50776021 | 1.77 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr14_+_22314715 | 1.76 |
ENST00000390434.3
|
TRAV8-2
|
T cell receptor alpha variable 8-2 |
chr1_+_39456895 | 1.76 |
ENST00000432648.3
ENST00000446189.2 ENST00000372984.4 |
AKIRIN1
|
akirin 1 |
chr12_+_56521840 | 1.75 |
ENST00000394048.5
|
ESYT1
|
extended synaptotagmin-like protein 1 |
chr2_+_70142232 | 1.75 |
ENST00000540449.1
|
MXD1
|
MAX dimerization protein 1 |
chr11_-_65429891 | 1.75 |
ENST00000527874.1
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A |
chr18_+_57567180 | 1.74 |
ENST00000316660.6
ENST00000269518.9 |
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1 |
chr7_-_142198049 | 1.73 |
ENST00000471935.1
|
TRBV11-2
|
T cell receptor beta variable 11-2 |
chr5_-_133304473 | 1.72 |
ENST00000231512.3
|
C5orf15
|
chromosome 5 open reading frame 15 |
chr15_-_55700457 | 1.72 |
ENST00000442196.3
ENST00000563171.1 ENST00000425574.3 |
CCPG1
|
cell cycle progression 1 |
chr8_-_116681686 | 1.71 |
ENST00000519815.1
|
TRPS1
|
trichorhinophalangeal syndrome I |
chr17_+_73089382 | 1.71 |
ENST00000538213.2
ENST00000584118.1 |
SLC16A5
|
solute carrier family 16 (monocarboxylate transporter), member 5 |
chr5_+_148206156 | 1.70 |
ENST00000305988.4
|
ADRB2
|
adrenoceptor beta 2, surface |
chr17_-_7155775 | 1.69 |
ENST00000571409.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
chr22_+_25003626 | 1.69 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
chrX_+_155110956 | 1.69 |
ENST00000286448.6
ENST00000262640.6 ENST00000460621.1 |
VAMP7
|
vesicle-associated membrane protein 7 |
chr17_-_77813186 | 1.68 |
ENST00000448310.1
ENST00000269397.4 |
CBX4
|
chromobox homolog 4 |
chr17_-_40540586 | 1.68 |
ENST00000264657.5
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor) |
chr19_-_51014588 | 1.68 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
chrX_+_12993336 | 1.67 |
ENST00000380635.1
|
TMSB4X
|
thymosin beta 4, X-linked |
chr10_+_99079008 | 1.66 |
ENST00000371021.3
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas |
chr16_+_68057153 | 1.65 |
ENST00000358896.6
ENST00000568099.2 |
DUS2
|
dihydrouridine synthase 2 |
chr16_+_30087288 | 1.65 |
ENST00000279387.7
ENST00000562664.1 ENST00000562222.1 |
PPP4C
|
protein phosphatase 4, catalytic subunit |
chr20_+_44420617 | 1.64 |
ENST00000449078.1
ENST00000456939.1 |
DNTTIP1
|
deoxynucleotidyltransferase, terminal, interacting protein 1 |
chr8_-_17103951 | 1.63 |
ENST00000520178.1
|
CNOT7
|
CCR4-NOT transcription complex, subunit 7 |
chrY_-_15591818 | 1.62 |
ENST00000382893.1
|
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
chr2_+_28113583 | 1.62 |
ENST00000344773.2
ENST00000379624.1 ENST00000342045.2 ENST00000379632.2 ENST00000361704.2 |
BRE
|
brain and reproductive organ-expressed (TNFRSF1A modulator) |
chr11_-_47400062 | 1.62 |
ENST00000533030.1
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr3_-_52312337 | 1.61 |
ENST00000469000.1
|
WDR82
|
WD repeat domain 82 |
chr2_+_135596106 | 1.61 |
ENST00000356140.5
|
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chr1_-_86861660 | 1.61 |
ENST00000486215.1
|
ODF2L
|
outer dense fiber of sperm tails 2-like |
chr6_-_38607628 | 1.60 |
ENST00000498633.1
|
BTBD9
|
BTB (POZ) domain containing 9 |
chr19_-_50528392 | 1.59 |
ENST00000600137.1
ENST00000597215.1 |
VRK3
|
vaccinia related kinase 3 |
chr3_+_42190714 | 1.58 |
ENST00000449246.1
|
TRAK1
|
trafficking protein, kinesin binding 1 |
chr1_+_174933899 | 1.58 |
ENST00000367688.3
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr14_+_22891362 | 1.57 |
ENST00000390469.2
|
TRDV2
|
T cell receptor delta variable 2 |
chr19_-_10341948 | 1.57 |
ENST00000590320.1
ENST00000592342.1 ENST00000588952.1 |
S1PR2
DNMT1
|
sphingosine-1-phosphate receptor 2 DNA (cytosine-5-)-methyltransferase 1 |
chr17_-_4643114 | 1.57 |
ENST00000293778.6
|
CXCL16
|
chemokine (C-X-C motif) ligand 16 |
chr17_-_43568062 | 1.56 |
ENST00000421073.2
ENST00000584420.1 ENST00000589780.1 ENST00000430334.3 |
PLEKHM1
|
pleckstrin homology domain containing, family M (with RUN domain) member 1 |
chr1_-_47184745 | 1.56 |
ENST00000544071.1
|
EFCAB14
|
EF-hand calcium binding domain 14 |
chr6_+_30029008 | 1.55 |
ENST00000332435.5
ENST00000376782.2 ENST00000359374.4 ENST00000376785.2 |
ZNRD1
|
zinc ribbon domain containing 1 |
chr9_-_86322831 | 1.55 |
ENST00000257468.7
|
UBQLN1
|
ubiquilin 1 |
chr7_+_44646177 | 1.54 |
ENST00000443864.2
ENST00000447398.1 ENST00000449767.1 ENST00000419661.1 |
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
chr7_+_44646162 | 1.54 |
ENST00000439616.2
|
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
chr1_+_26496362 | 1.54 |
ENST00000374266.5
ENST00000270812.5 |
ZNF593
|
zinc finger protein 593 |
chr19_+_18283959 | 1.53 |
ENST00000597802.2
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr16_+_50775971 | 1.52 |
ENST00000311559.9
ENST00000564326.1 ENST00000566206.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr14_+_50359773 | 1.52 |
ENST00000298316.5
|
ARF6
|
ADP-ribosylation factor 6 |
chrX_-_106960285 | 1.52 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
chr4_-_104119488 | 1.52 |
ENST00000514974.1
|
CENPE
|
centromere protein E, 312kDa |
chr20_+_30697298 | 1.52 |
ENST00000398022.2
|
TM9SF4
|
transmembrane 9 superfamily protein member 4 |
chr1_+_29213678 | 1.52 |
ENST00000347529.3
|
EPB41
|
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
chr3_-_71632894 | 1.51 |
ENST00000493089.1
|
FOXP1
|
forkhead box P1 |
chr3_+_43328004 | 1.51 |
ENST00000454177.1
ENST00000429705.2 ENST00000296088.7 ENST00000437827.1 |
SNRK
|
SNF related kinase |
chr3_+_170075436 | 1.51 |
ENST00000476188.1
ENST00000259119.4 ENST00000426052.2 |
SKIL
|
SKI-like oncogene |
chr5_+_138210919 | 1.51 |
ENST00000522013.1
ENST00000520260.1 ENST00000523298.1 ENST00000520865.1 ENST00000519634.1 ENST00000517533.1 ENST00000523685.1 ENST00000519768.1 ENST00000517656.1 ENST00000521683.1 ENST00000521640.1 ENST00000519116.1 |
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa |
chr12_+_75874984 | 1.51 |
ENST00000550491.1
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr9_-_77643189 | 1.50 |
ENST00000376837.3
|
C9orf41
|
chromosome 9 open reading frame 41 |
chr17_-_47785504 | 1.50 |
ENST00000514907.1
ENST00000503334.1 ENST00000508520.1 |
SLC35B1
|
solute carrier family 35, member B1 |
chr22_-_39096925 | 1.50 |
ENST00000456626.1
ENST00000412832.1 |
JOSD1
|
Josephin domain containing 1 |
chr17_-_49124230 | 1.50 |
ENST00000510283.1
ENST00000510855.1 |
SPAG9
|
sperm associated antigen 9 |
chrY_-_15591485 | 1.49 |
ENST00000382896.4
ENST00000537580.1 ENST00000540140.1 ENST00000545955.1 ENST00000538878.1 |
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
chr6_-_42713792 | 1.49 |
ENST00000372876.1
|
TBCC
|
tubulin folding cofactor C |
chr6_+_35227449 | 1.48 |
ENST00000373953.3
ENST00000440666.2 ENST00000339411.5 |
ZNF76
|
zinc finger protein 76 |
chr7_+_44646218 | 1.47 |
ENST00000444676.1
ENST00000222673.5 |
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
chr6_-_27440460 | 1.47 |
ENST00000377419.1
|
ZNF184
|
zinc finger protein 184 |
chr7_+_142494244 | 1.46 |
ENST00000390413.1
|
TRBJ2-2
|
T cell receptor beta joining 2-2 |
chr14_+_55738021 | 1.46 |
ENST00000313833.4
|
FBXO34
|
F-box protein 34 |
chr8_+_42552503 | 1.45 |
ENST00000534391.1
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal) |
chr18_+_61564389 | 1.45 |
ENST00000397996.2
ENST00000418725.1 |
SERPINB10
|
serpin peptidase inhibitor, clade B (ovalbumin), member 10 |
chr13_-_52378231 | 1.45 |
ENST00000280056.2
ENST00000444610.2 |
DHRS12
|
dehydrogenase/reductase (SDR family) member 12 |
chr16_+_68057179 | 1.45 |
ENST00000567100.1
ENST00000432752.1 ENST00000569289.1 ENST00000564781.1 |
DUS2
|
dihydrouridine synthase 2 |
chr6_-_24877490 | 1.44 |
ENST00000540914.1
ENST00000378023.4 |
FAM65B
|
family with sequence similarity 65, member B |
chr10_+_35484793 | 1.44 |
ENST00000488741.1
ENST00000474931.1 ENST00000468236.1 ENST00000344351.5 ENST00000490511.1 |
CREM
|
cAMP responsive element modulator |
chr19_-_42759266 | 1.44 |
ENST00000594664.1
|
AC006486.9
|
Uncharacterized protein |
chr8_-_116680833 | 1.43 |
ENST00000220888.5
|
TRPS1
|
trichorhinophalangeal syndrome I |
chr17_-_40540377 | 1.43 |
ENST00000404395.3
ENST00000389272.3 ENST00000585517.1 ENST00000588065.1 |
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor) |
chrX_+_9431324 | 1.43 |
ENST00000407597.2
ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X
|
transducin (beta)-like 1X-linked |
chr11_+_122709200 | 1.43 |
ENST00000227348.4
|
CRTAM
|
cytotoxic and regulatory T cell molecule |
chr17_-_47785265 | 1.42 |
ENST00000511763.1
ENST00000515850.1 ENST00000415270.2 ENST00000240333.6 |
SLC35B1
|
solute carrier family 35, member B1 |
chr17_+_38497640 | 1.42 |
ENST00000394086.3
|
RARA
|
retinoic acid receptor, alpha |
chr1_-_93645818 | 1.42 |
ENST00000370280.1
ENST00000479918.1 |
TMED5
|
transmembrane emp24 protein transport domain containing 5 |
chr11_+_117049445 | 1.42 |
ENST00000324225.4
ENST00000532960.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr2_-_202645835 | 1.42 |
ENST00000264276.6
|
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile) |
chr13_-_52378281 | 1.41 |
ENST00000218981.1
|
DHRS12
|
dehydrogenase/reductase (SDR family) member 12 |
chr15_-_73075964 | 1.41 |
ENST00000563907.1
|
ADPGK
|
ADP-dependent glucokinase |
chr19_-_50528584 | 1.40 |
ENST00000594092.1
ENST00000443401.2 ENST00000594948.1 ENST00000377011.2 ENST00000593919.1 ENST00000601324.1 ENST00000316763.3 ENST00000601341.1 ENST00000600259.1 |
VRK3
|
vaccinia related kinase 3 |
chr4_-_77997126 | 1.40 |
ENST00000537948.1
ENST00000507788.1 ENST00000237654.4 |
CCNI
|
cyclin I |
chr17_-_7155274 | 1.40 |
ENST00000318988.6
ENST00000575783.1 ENST00000573600.1 |
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
chr20_-_39317868 | 1.39 |
ENST00000373313.2
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
chr5_+_112849373 | 1.39 |
ENST00000161863.4
ENST00000515883.1 |
YTHDC2
|
YTH domain containing 2 |
chr5_-_175964366 | 1.39 |
ENST00000274811.4
|
RNF44
|
ring finger protein 44 |
chr7_+_120590803 | 1.39 |
ENST00000315870.5
ENST00000339121.5 ENST00000445699.1 |
ING3
|
inhibitor of growth family, member 3 |
chr9_+_125027127 | 1.39 |
ENST00000441707.1
ENST00000373723.5 ENST00000373729.1 |
MRRF
|
mitochondrial ribosome recycling factor |
chr16_+_85942594 | 1.39 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
chr1_+_29213584 | 1.38 |
ENST00000343067.4
ENST00000356093.2 ENST00000398863.2 ENST00000373800.3 ENST00000349460.4 |
EPB41
|
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
chr19_-_47734448 | 1.38 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
chr14_+_60716159 | 1.38 |
ENST00000325658.3
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A |
chr7_+_127228399 | 1.38 |
ENST00000000233.5
ENST00000415666.1 |
ARF5
|
ADP-ribosylation factor 5 |
chr17_-_7155802 | 1.37 |
ENST00000572043.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.8 | 5.3 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
1.2 | 3.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.1 | 3.2 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
1.0 | 4.8 | GO:1902728 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.9 | 4.7 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.9 | 2.7 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.9 | 2.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.8 | 3.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.8 | 3.4 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.8 | 2.5 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
0.8 | 4.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.8 | 4.8 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.8 | 3.9 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.8 | 4.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.8 | 2.3 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.7 | 6.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.7 | 2.9 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.7 | 2.1 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.7 | 2.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.7 | 4.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.7 | 4.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.7 | 2.0 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
0.7 | 5.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.6 | 1.9 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 1.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.6 | 1.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.5 | 4.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.5 | 5.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.5 | 2.1 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.5 | 1.6 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.5 | 2.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.5 | 2.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.5 | 1.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.5 | 10.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 2.5 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.5 | 4.9 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.5 | 5.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.5 | 0.5 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.5 | 1.4 | GO:0071336 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
0.5 | 1.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.5 | 1.8 | GO:0009386 | translational attenuation(GO:0009386) |
0.5 | 2.7 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.4 | 1.3 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.4 | 2.6 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.4 | 1.3 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.4 | 2.1 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.4 | 0.4 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.4 | 2.5 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.4 | 2.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 2.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.4 | 1.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.4 | 2.7 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.4 | 1.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.4 | 1.1 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) positive regulation of leukocyte tethering or rolling(GO:1903238) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.4 | 1.1 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.4 | 1.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.4 | 1.8 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.3 | 2.1 | GO:0032571 | response to vitamin K(GO:0032571) |
0.3 | 1.0 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.3 | 1.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 0.7 | GO:0048511 | rhythmic process(GO:0048511) |
0.3 | 1.3 | GO:0031081 | nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
0.3 | 3.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.3 | 0.3 | GO:2000458 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
0.3 | 1.9 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.3 | 4.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 4.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.9 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 1.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 1.5 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.3 | 3.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 0.3 | GO:0051604 | protein maturation(GO:0051604) |
0.3 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 1.1 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.3 | 1.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.3 | 2.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 2.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.1 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.3 | 0.8 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.3 | 1.1 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.3 | 0.8 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.3 | 1.1 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
0.3 | 0.8 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
0.3 | 1.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.3 | 0.8 | GO:0021503 | neural fold bending(GO:0021503) |
0.3 | 5.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.3 | 2.0 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.3 | 1.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 1.2 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.7 | GO:1901253 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of intracellular transport of viral material(GO:1901253) |
0.2 | 1.7 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 1.0 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.2 | 1.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.5 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.2 | 1.1 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.2 | 1.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.2 | 0.9 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.2 | 1.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 1.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 2.0 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.2 | 0.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.2 | 1.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 3.2 | GO:0000050 | urea cycle(GO:0000050) |
0.2 | 2.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.2 | 0.6 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 2.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.6 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 0.6 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.2 | 0.8 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.2 | 1.6 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.2 | 0.4 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.2 | 1.0 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.2 | 1.6 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.2 | 2.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.2 | 1.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 2.5 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 1.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.6 | GO:2001258 | negative regulation of voltage-gated calcium channel activity(GO:1901386) negative regulation of high voltage-gated calcium channel activity(GO:1901842) negative regulation of cation channel activity(GO:2001258) |
0.2 | 0.8 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.2 | 1.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 2.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.6 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.2 | 0.9 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 0.7 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.2 | 0.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 0.6 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.2 | 0.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.2 | 1.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.2 | 3.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 1.1 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.2 | 2.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.7 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.2 | 1.0 | GO:2000503 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.9 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.2 | 3.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 2.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.7 | GO:1990637 | response to prolactin(GO:1990637) |
0.2 | 2.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.9 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 2.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 1.0 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 1.8 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.2 | 1.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 1.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 2.0 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.2 | 2.6 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.2 | 0.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.2 | 1.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.2 | 2.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 4.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.2 | 0.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.2 | 0.2 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 | 1.1 | GO:0060356 | leucine import(GO:0060356) |
0.2 | 0.6 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 0.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 1.2 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.1 | 0.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 4.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.1 | 0.7 | GO:0060577 | pulmonary vein morphogenesis(GO:0060577) |
0.1 | 0.3 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.1 | 5.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.6 | GO:0055099 | detection of endogenous stimulus(GO:0009726) response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.4 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.7 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 2.3 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 0.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.4 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 2.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.7 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.1 | 1.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.7 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.1 | 0.7 | GO:0061528 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.1 | 0.7 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 1.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.8 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.1 | 0.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 6.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.5 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 0.4 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.1 | 0.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 2.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 1.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 1.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.4 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 1.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.5 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.1 | 0.4 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.4 | GO:0018364 | box C/D snoRNA 3'-end processing(GO:0000494) peptidyl-glutamine methylation(GO:0018364) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.1 | 0.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.4 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.1 | 0.6 | GO:0008203 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.1 | 2.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 1.8 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.4 | GO:0002584 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 1.5 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.7 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.4 | GO:0000732 | strand displacement(GO:0000732) |
0.1 | 0.7 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.8 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.1 | 1.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 4.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.3 | GO:0042327 | positive regulation of phosphorylation(GO:0042327) |
0.1 | 0.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.9 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.5 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 2.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.4 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.8 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.5 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.3 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 1.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.2 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.4 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.1 | 0.3 | GO:0039020 | pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric nephron tubule development(GO:0039020) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) Kupffer's vesicle development(GO:0070121) |
0.1 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 1.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.5 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.1 | 0.4 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.1 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.6 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 1.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 0.8 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 1.0 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.7 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 2.6 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.6 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 1.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.8 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 2.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.8 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 0.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 2.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 1.7 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.1 | 1.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.8 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 6.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.3 | GO:1902824 | cleavage furrow ingression(GO:0036090) lysosomal membrane organization(GO:0097212) positive regulation of late endosome to lysosome transport(GO:1902824) |
0.1 | 0.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 4.4 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 4.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 0.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.9 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.4 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 2.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 5.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 2.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.6 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 2.7 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 0.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 2.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.8 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.1 | 0.3 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.1 | 0.3 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.1 | GO:0010628 | positive regulation of gene expression(GO:0010628) |
0.1 | 0.3 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 1.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 1.7 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.1 | 0.2 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.1 | 0.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 1.9 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.1 | 0.9 | GO:1901184 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 1.0 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 4.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 2.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.3 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 2.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.8 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.1 | 1.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.1 | 0.5 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 1.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 6.6 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.1 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.1 | 0.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.4 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 1.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 1.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.6 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.8 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 2.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.1 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.7 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.1 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.1 | 0.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 3.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 5.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 1.3 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 1.6 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 1.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0052501 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 1.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 1.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.7 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.1 | 0.6 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.3 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.3 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.1 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.1 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 1.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 1.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.4 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.4 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 1.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.2 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.1 | 1.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.4 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 1.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.5 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 0.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 1.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.5 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 1.8 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 1.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 1.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 1.0 | GO:0048864 | stem cell development(GO:0048864) |
0.1 | 0.4 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.1 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 2.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.4 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.1 | 0.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.8 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 7.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.3 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.1 | 4.4 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.2 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.1 | 0.5 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 1.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.2 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.7 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.1 | 0.2 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.1 | 0.6 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 5.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 1.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:0090370 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.9 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 1.0 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.7 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.1 | 0.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.2 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.1 | 0.4 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
0.0 | 6.2 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 2.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.7 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.0 | 0.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.0 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.9 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.4 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.0 | 2.9 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.8 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 0.9 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.0 | 0.3 | GO:1901355 | cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
0.0 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.0 | 1.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.4 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.0 | 0.8 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 1.1 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 1.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 1.7 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.0 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.0 | 0.1 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.0 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.2 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.0 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.0 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.7 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.2 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.0 | 0.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.0 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.0 | 1.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 2.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.0 | GO:0090209 | negative regulation of triglyceride biosynthetic process(GO:0010868) negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.4 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.9 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 1.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 1.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.5 | GO:0007254 | JNK cascade(GO:0007254) |
0.0 | 0.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0048806 | genitalia development(GO:0048806) |
0.0 | 0.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 2.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 6.1 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.1 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.9 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 2.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 1.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) snRNA pseudouridine synthesis(GO:0031120) snRNA modification(GO:0040031) |
0.0 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 3.1 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.1 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
0.0 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 1.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.6 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.0 | 1.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 1.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 1.4 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.8 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.5 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.4 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 1.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.1 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 1.9 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 1.4 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.2 | GO:0031098 | stress-activated protein kinase signaling cascade(GO:0031098) |
0.0 | 0.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.8 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.4 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 2.1 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.0 | 0.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.2 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.0 | 0.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.5 | GO:1902230 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.9 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.3 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:1901090 | protein import into peroxisome matrix, docking(GO:0016560) regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.0 | 0.1 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.0 | 6.7 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.0 | 0.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 2.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.0 | 0.1 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.0 | 0.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.1 | GO:0048239 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) regulation of single strand break repair(GO:1903516) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.0 | 0.1 | GO:0002526 | acute inflammatory response(GO:0002526) |
0.0 | 0.4 | GO:0019532 | oxalate transport(GO:0019532) sulfate transmembrane transport(GO:1902358) |
0.0 | 0.6 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 4.1 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.3 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.6 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.6 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.9 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.0 | 0.5 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.2 | GO:0006403 | RNA localization(GO:0006403) |
0.0 | 0.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.2 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.1 | GO:0043648 | dicarboxylic acid metabolic process(GO:0043648) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 1.0 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.0 | 0.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.2 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.3 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 2.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.3 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
0.0 | 0.2 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 8.2 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 0.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.0 | 1.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.7 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 0.8 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0006751 | glutathione catabolic process(GO:0006751) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 0.9 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.8 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.2 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 1.4 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.0 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 0.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.8 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.4 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.0 | 0.3 | GO:0051216 | cartilage development(GO:0051216) |
0.0 | 0.7 | GO:0015918 | sterol transport(GO:0015918) |
0.0 | 0.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.1 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.0 | 0.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | GO:0075341 | host cell PML body(GO:0075341) |
1.1 | 3.2 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.7 | 4.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.7 | 5.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.6 | 2.5 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.5 | 0.9 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.5 | 5.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 1.1 | GO:0097447 | dendritic tree(GO:0097447) |
0.4 | 0.7 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.4 | 1.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 1.1 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.3 | 5.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 10.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 1.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 3.4 | GO:0033503 | HULC complex(GO:0033503) |
0.3 | 2.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 1.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.3 | 2.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 3.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 0.8 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 2.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.7 | GO:0070685 | macropinocytic cup(GO:0070685) |
0.2 | 4.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 3.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 2.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 5.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.7 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.2 | 4.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 3.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 2.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.8 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 2.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 1.2 | GO:0001652 | granular component(GO:0001652) |
0.2 | 4.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 4.8 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.2 | 1.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 1.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 4.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 0.8 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.2 | 2.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.4 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.1 | 0.9 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 0.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.1 | 1.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.7 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 0.4 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.1 | 1.0 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 2.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.5 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.1 | 1.0 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 1.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 2.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.4 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.1 | 1.0 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 2.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 4.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 1.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.1 | GO:0070993 | translation preinitiation complex(GO:0070993) |
0.1 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.4 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 2.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 2.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 2.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 3.7 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 2.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.7 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.6 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.6 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 8.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 1.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 3.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 4.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 3.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 3.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 2.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 4.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.8 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.1 | 0.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 1.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 1.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 2.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 5.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 1.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.2 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 6.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 5.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.1 | GO:0031906 | late endosome lumen(GO:0031906) |
0.1 | 0.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 2.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 1.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.4 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 8.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 27.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 4.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 1.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 1.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 1.7 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 2.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 6.2 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.3 | GO:0036019 | endolysosome(GO:0036019) |
0.0 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 18.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 1.3 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 5.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.0 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 7.3 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.2 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.0 | 4.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 3.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.3 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 2.1 | GO:0005844 | polysome(GO:0005844) |
0.0 | 16.5 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.6 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.2 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.0 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 4.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 1.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 3.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.3 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.0 | 1.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 2.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 1.3 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.1 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.0 | 0.2 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.0 | 1.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.4 | GO:0030681 | multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 2.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 1.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 1.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 2.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 1.7 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 1.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 1.8 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 2.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.1 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.0 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 14.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 8.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.0 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.4 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.1 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 5.2 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.2 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 3.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0097196 | Shu complex(GO:0097196) |
0.0 | 0.5 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 3.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 6.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 12.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 32.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.3 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.5 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
1.2 | 4.9 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.9 | 2.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.8 | 2.5 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.8 | 4.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.7 | 6.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.7 | 2.9 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.7 | 2.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.7 | 4.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 1.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.5 | 5.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 3.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 1.6 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.5 | 1.5 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.5 | 1.5 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.5 | 4.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 1.4 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.5 | 1.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.5 | 1.8 | GO:0032427 | GBD domain binding(GO:0032427) |
0.5 | 1.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.5 | 2.7 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.4 | 1.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.4 | 1.3 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.4 | 5.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 4.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.4 | 2.4 | GO:0039552 | RIG-I binding(GO:0039552) |
0.4 | 2.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 2.7 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.4 | 1.1 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.4 | 1.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.3 | 1.0 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.3 | 1.0 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.3 | 1.3 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.3 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 5.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.3 | 3.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 1.5 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.3 | 1.8 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.3 | 1.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.3 | 3.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 1.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 1.1 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
0.3 | 0.8 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.3 | 1.3 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.3 | 0.8 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.3 | 2.9 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 14.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 1.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 2.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 1.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.2 | 5.0 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 5.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 2.2 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.0 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.2 | 1.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.4 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 0.7 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.2 | 0.7 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.2 | 2.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 5.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 3.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.9 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.2 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 4.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.9 | GO:0047977 | linoleate 13S-lipoxygenase activity(GO:0016165) hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.2 | 0.9 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 3.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 2.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 2.1 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 1.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.6 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 1.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.2 | 5.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 1.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.2 | 2.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 2.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 1.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 0.8 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.2 | 0.6 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.2 | 1.0 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.2 | 0.7 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 4.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 0.6 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
0.2 | 0.5 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.2 | 4.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.5 | GO:0005135 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
0.2 | 1.1 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.2 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.5 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
0.2 | 0.5 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.2 | 1.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 4.7 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 1.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 1.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.2 | 1.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 1.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 1.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.2 | 1.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.4 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.1 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 1.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 2.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.4 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.1 | 2.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 1.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 4.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 0.4 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.1 | 0.7 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.1 | 0.7 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.1 | 2.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 2.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.4 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.1 | 2.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 0.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.4 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 0.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 2.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 6.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.8 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 1.1 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 0.7 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
0.1 | 1.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.8 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.1 | 0.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 4.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 1.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 1.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.5 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 1.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 4.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 2.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.5 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.1 | 0.7 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.1 | 0.3 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 1.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 1.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 1.0 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.1 | 3.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 2.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.5 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.1 | 0.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.3 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.1 | 1.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 2.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 6.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.4 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.1 | 2.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 2.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 4.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 3.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 5.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 7.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 0.5 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.1 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 1.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.5 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.1 | 5.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 4.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.3 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 0.2 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 2.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 6.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 3.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 6.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 2.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.2 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 2.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.7 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 2.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.1 | 1.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.3 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.1 | 2.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.6 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.6 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 2.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 1.0 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.4 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 2.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 1.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 0.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.1 | 1.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 19.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 1.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 1.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 4.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 1.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 1.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.3 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 3.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 1.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 1.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.0 | 1.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 1.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 1.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.0 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.2 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 1.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 7.7 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.4 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.0 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 10.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 2.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 12.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 1.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.9 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.0 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.0 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 1.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 1.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 1.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 1.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 2.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 2.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.5 | GO:0003909 | DNA ligase activity(GO:0003909) |
0.0 | 1.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 4.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.1 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
0.0 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.9 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.7 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 1.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 1.0 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.0 | 0.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 2.3 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.2 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 8.4 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.6 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.2 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.0 | 0.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 1.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 1.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 1.6 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.6 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 1.7 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 1.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 1.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.7 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 1.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 4.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.3 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.4 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 1.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 3.6 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.6 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.0 | 0.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.0 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.0 | 0.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 2.4 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.7 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 2.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.3 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 1.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.1 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.0 | 0.1 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 2.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 4.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 1.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 4.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 9.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 10.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 5.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.1 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 5.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 2.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 4.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 10.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 3.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 12.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 5.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 9.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 3.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 9.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 5.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 2.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 6.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.3 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 2.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 3.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 5.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 4.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 3.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 3.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 1.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 2.7 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 2.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 1.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 1.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 1.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 2.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 3.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 8.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 4.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 6.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 7.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 3.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 3.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 3.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 3.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 8.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 3.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 3.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 3.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 7.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 3.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 5.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 3.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 2.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 4.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 3.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 4.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 4.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 6.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 2.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 3.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 2.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 6.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 3.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 4.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 2.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 1.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 2.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 5.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 1.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 1.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 2.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 1.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 12.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 3.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 2.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 2.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 1.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 2.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 1.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 1.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 2.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 1.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 2.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 2.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 1.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 2.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.3 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 2.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 2.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 2.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 1.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |